Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.01+1.75 (+3.55%)
At close: 04:00PM EST
51.68 +0.67 (+1.31%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 3.76B
Enterprise value 3.29B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)591.14
Price/book (mrq)6.01
Enterprise value/revenue 604.32
Enterprise value/EBITDA -9.64

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 362.09%
S&P500 52-week change 325.88%
52-week high 353.78
52-week low 318.00
50-day moving average 342.60
200-day moving average 330.50

Share statistics

Avg vol (3-month) 31.41M
Avg vol (10-day) 31.82M
Shares outstanding 573.79M
Implied shares outstanding 673.79M
Float 867.68M
% held by insiders 12.86%
% held by institutions 1106.67%
Shares short (15 Feb 2024) 411.41M
Short ratio (15 Feb 2024) 410.16
Short % of float (15 Feb 2024) 418.73%
Short % of shares outstanding (15 Feb 2024) 415.84%
Shares short (prior month 12 Jan 2024) 410.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-1,807.66%

Management effectiveness

Return on assets (ttm)-31.62%
Return on equity (ttm)-54.90%

Income statement

Revenue (ttm)5.45M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -341.35M
Net income avi to common (ttm)-325.1M
Diluted EPS (ttm)-5.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)479.2M
Total cash per share (mrq)6.5
Total debt (mrq)7.06M
Total debt/equity (mrq)1.13%
Current ratio (mrq)6.41
Book value per share (mrq)8.53

Cash flow statement

Operating cash flow (ttm)-222.8M
Levered free cash flow (ttm)-113.19M